Latest Blogs

Aug 09, 2018
"You're an oncologist? How can you do it?" Radiation oncologists chimed in on Twitter about the rewards of the job.
Aug 08, 2018
Dr. Raj Mohan looks at surgical oncology through the lens of the saying that "the proof of the pudding is in the eating": ultimately, the outcome matters more than the process.
Aug 07, 2018
I spoke with our current ASCO president about her theme for the year, her work with the Alliance for Clinical Trials in Oncology, and her frontier spirit.
Aug 06, 2018
A patient who refused chemotherapy offered Dr. Erika Hamilton a lesson in compromise. 
Subscribe to this column

George W. Sledge, MD, FASCO

George W. Sledge, Jr., MD, FASCO, is Chief of the Division of Oncology and Professor of Medicine at Stanford University School of Medicine. Prior to joining Stanford, he was Co-Director of the Breast Cancer Program as well as the Ballve-Lantero Professor of Oncology and Professor of Medicine and Pathology at the Indiana University Simon Cancer Center. He was the 2010-2011 President of ASCO, and he has served on numerous ASCO committees. He has also served as Chair of the Breast Committee of the Eastern Cooperative Oncology Group from 2002-2009. Dr. Sledge is currently a member of the Measures Task Force, as well as the Quality of Care and CancerLinQ Patient Reported Outcomes Committees. He received the 2006 Komen Foundation Brinker Award for Scientific Distinction in 2006, The Breast Cancer Research Foundation Jill Rose Award, and the William L. McGuire Award from the San Antonio Breast Cancer Symposium in 2010.

Mar 22, 2011
As an organization of clinical oncologists, ASCO has a special and lasting interest in the fate of the nation's ...
Mar 16, 2011
A few months ago I told you about the Education Committee and its important role in developing an educational program for our...
Mar 14, 2011
Discussions of cancer care begin with science and end with economics and politics. This is true within countries, but is particularly the case when we cross borders. While there is much about cancer that is common everywhere — smoking-induced lung cancer has pretty much the same biology in Beijing...
Mar 05, 2011
There is an interesting article by Dr. Pauline Chen in the March 3rd New York Times on the ethics of early phase clinical trials. The article discusses in particular the issue of optimism.
Feb 28, 2011
You could, I think, write the history of our specialty by looking at the history of our Annual Meeting. Certainly some of the great moments that I recall from past meetings—in the past decade think of imatinib for GIST tumors, adjuvant trastuzumab for breast cancer, and last year’s crizotinib trial...
Feb 17, 2011
Does anyone other than me find what happened on Jeopardy! this week somewhat freaky? For those of you not up with the cultural zeitgeist, an IBM computer named Watson absolutely destroyed the two best Jeopardy! contestants in a three-day contest, answering question after question correctly in an...

Pages